🟢 Oncolytics Biotech is trading 6.92% up today after rebounding from September 11’s $0.75 close

Oncolytics Biotech is trading 6.92% up at $0.80 after rebounding from the $0.75 close on September 11, 2026.

• No clear company-specific catalyst has been identified for the September 14 move.
• The September 10 announcement of positive preclinical pelareorep results involving a pan-RAS inhibitor remains the latest notable company news, but available coverage does not directly link it to today’s gain.
• Broader markets are modestly lower, so market-wide sentiment does not clearly explain the advance.